MedTrace Logo

A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy

NCT05769855 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 294

Last updated 2024-03-07

No results posted yet for this study

Summary

The study is being conducted to evaluate the efficacy, and safety of HR18034 for postoperative analgesia in subjects undergoing hemorrhoidectomy.

Conditions

  • Postsurgical Pain Management

Interventions

DRUG

HR18034

HR18034 380mg

DRUG

ropivacaine HCl

ropivacaine HCl 75mg.

DRUG

Sodium Chloride Physiological Solution

Sodium Chloride Physiological Solution 20ml

Sponsors & Collaborators

  • Shanghai Hengrui Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-21
Primary Completion
2023-10-30
Completion
2023-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05769855 on ClinicalTrials.gov